Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines

Cheng, 2000, Type III machines of Gram-negative bacteria: delivering the goods, Trends Microbiol, 8, 214, 10.1016/S0966-842X(99)01665-0 Vallis, 1999, Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions, Infect Immun, 67, 914, 10.1128/IAI.67.2.914-920.1999 Berthelot, 2003, Genotypic and phenotypic analysis of type III secretion system in cohort of Pseudomonas aeruginosa bacteriemia isolates: evidence for a possible association between O serotypes and exo genes, J Infect Dis, 188, 512, 10.1086/377000 Hauser, 1999, Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells, Infect Immun, 67, 5530, 10.1128/IAI.67.10.5530-5537.1999 Dacheux, 2000, Pseudomonas aeruginosa cystic fibrosis isolates induce rapid type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils, Infect Immun, 68, 2916, 10.1128/IAI.68.5.2916-2924.2000 Hauser, 2002, Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa, Crit Care Med, 30, 521, 10.1097/00003246-200203000-00005 Fink-Barbancon, 1997, ExoU expresion by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury, Mol Microbiol, 25, 547, 10.1046/j.1365-2958.1997.4891851.x Cowell, 2000, ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells, Infect Immun, 68, 403, 10.1128/IAI.68.1.403-406.2000 Valente, 2000, Pseudomonas aeruginosa induces apoptosis in human endothelial cells, Microb Pathog, 29, 345, 10.1006/mpat.2000.0400 Saliba, 2002, Type III secretion-mediated killing of endothelial cells by Pseudomonas aeruginosa, Microb Pathog, 33, 153, 10.1016/S0882-4010(02)90522-X Saliba, 2003, ExoU contributes to late killing of Pseudomonas aeruginosa-infected endothelial cells, Braz J Microbiol, 34, 25, 10.1590/S1517-83822003000500008 Sayner, 2004, Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY, Circ Res, 95, 196, 10.1161/01.RES.0000134922.25721.d9 Brigham, 1974, Increased sheep lung vascular permeability caused by Pseudomonas bacteremia, J Clin Invest, 54, 792, 10.1172/JCI107819 Von Götz, 2004, Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis, J Bacteriol, 186, 3837, 10.1128/JB.186.12.3837-3847.2004 Feltman, 2001, Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa, Microbiology, 147, 2659, 10.1099/00221287-147-10-2659 Ohara, 2003, Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract, Intern Med, 42, 1072, 10.2169/internalmedicine.42.1072 Ajayi, 2003, Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system, J Clin Microbiol, 41, 3526, 10.1128/JCM.41.8.3526-3531.2003 Nicas, 1984, Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S, Infect Immun, 45, 470, 10.1128/IAI.45.2.470-474.1984 Li, 2005, An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of type III virulence phenotypes of Pseudomonas aeruginosa isolates, Ann Clin Microbiol Antimicrob, 4, 22, 10.1186/1476-0711-4-22 Wareham, 2007, A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates, Int J Med Microbiol, 4, 227, 10.1016/j.ijmm.2007.02.004 Fleiszig, 1997, Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S, Infect Immun, 65, 579, 10.1128/IAI.65.2.579-586.1997 Schulert, 2003, Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia, J. Infect Dis, 188, 1695, 10.1086/379372 Ferguson, 2001, Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa, Infect Immun, 69, 2198, 10.1128/IAI.69.4.2198-2210.2001 Allmond, 2004, V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa, Clin Microbiol, 42, 3857, 10.1128/JCM.42.8.3857-3860.2004 Shaver, 2006, Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals, Microbiology, 152, 143, 10.1099/mic.0.28368-0 Jain, 2004, Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis, J Clin Microbiol, 42, 5229, 10.1128/JCM.42.11.5229-5237.2004 Coburn, 1999, Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system, Infect Immun, 67, 3151, 10.1128/IAI.67.6.3151-3154.1999 Rucks, 2003, Cell line differences in bacterially translocated ExoS ADP-ribosyltransferase substrate specificity, Microbiology, 149, 319, 10.1099/mic.0.25985-0 Pimenta, 2006, Positive correlation between in vivo and in vitro assays for the evaluation of Pseudomonas virulence, Res Microbiol, 159, 889 Filopon, 2006, Epigenetic acquisition of inducibility of type III cytotoxicity in Pseudomonas aeruginosa, BMC Bioinformatics, 7, 272, 10.1186/1471-2105-7-272 Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature, 406, 959, 10.1038/35023079 Lakkis, 2001, Resistance of Pseudomonas aeruginosa isolates to hydrogel contact lens disinfection correlates with cytotoxic activity, J Clin Microbiol, 39, 1477, 10.1128/JCM.39.4.1477-1486.2001 Atlas, 1997 Rozen, 2000, Primer3 on the WWW for general users and for biologist programmers, 365 Dong, 1997, A general strategy for endothelial cells from murine tissues, Arterioscler Thromb Vasc Biol, 17, 1599, 10.1161/01.ATV.17.8.1599 Mosmann, 1983, Rapid colorimetric assay for cellular grown and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Sawa, 1998, In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections, Infect Immun, 66, 3242, 10.1128/IAI.66.7.3242-3249.1998 Plotkowski, 1994, Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells, Infect Immun, 62, 5456, 10.1128/IAI.62.12.5456-5463.1994